Actylis Overview
- Year Founded
-
1947
- Status
-
Private
- Employees
-
850
- Latest Deal Type
-
Corporate
- Financing Rounds
-
5
- Investments
-
11
Actylis General Information
Description
Manufacturer and distributor of raw materials and performance ingredients intended to serve the pharmaceutical, biopharmaceutical, nutrition, cosmetics, specialty chemicals, and agriscience industries. The company offers liquid buffers, cell cultures, intermediates, and reagents and also analytical services, and contract manufacturing, thereby helping businesses to rapidly develop and commercialize their products.
Contact Information
Website
www.actylis.comCorporate Office
- 4 Tri Harbor Court
- Port Washington, NY 11050
- United States
Corporate Office
- 4 Tri Harbor Court
- Port Washington, NY 11050
- United States
Actylis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Actylis Comparisons
Industry
Financing
Details
Actylis Competitors (14)
One of Actylis’s 14 competitors is WeylChem International, a Corporate Backed or Acquired company based in Frankfurt, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| WeylChem International | Corporate Backed or Acquired | Frankfurt, Germany | ||||
| ABITEC | Corporate Backed or Acquired | Columbus, OH | ||||
| Celanese | Formerly PE-Backed | Irving, TX | ||||
| Hallstar Innovations | Private Debt Financed | Chicago, IL | ||||
| American Pacific | Formerly PE-Backed | Cedar City, UT |
Actylis Signals
Actylis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Actylis Investments & Acquisitions (11)
Actylis’s most recent deal was a Buyout/LBO with Pharm-Rx. The deal was made on 07-Oct-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pharm-Rx | 07-Oct-2024 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Biotron Laboratories | 02-Mar-2022 | Buyout/LBO | Specialty Chemicals | ||
| A&C Bio Buffer | 12-Oct-2021 | Merger/Acquisition | Specialty Chemicals | ||
| Cascade Chemistry | 02-Jun-2021 | Merger/Acquisition | BPO/Outsource Services | ||
| Finar Chemicals | 17-May-2021 | Buyout/LBO | Multi-line Chemicals |
Actylis Exits (2)
Actylis’s most recent exit was on 02-Jun-2021 from Cascade Chemistry. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Cascade Chemistry | 02-Jun-2021 | Completed |
|
||
| Rising Pharma Holdings | 31-Dec-2010 | Merger/Acquisition | Completed |
Actylis Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Pharm-Rx | Saddle Brook, NJ | 1991 |
Actylis FAQs
-
When was Actylis founded?
Actylis was founded in 1947.
-
Where is Actylis headquartered?
Actylis is headquartered in Port Washington, NY.
-
What is the size of Actylis?
Actylis has 850 total employees.
-
What industry is Actylis in?
Actylis’s primary industry is Specialty Chemicals.
-
Is Actylis a private or public company?
Actylis is a Private company.
-
What is Actylis’s current revenue?
The current revenue for Actylis is .
-
How much funding has Actylis raised over time?
Actylis has raised $21.2M.
-
Who are Actylis’s investors?
New Mountain Capital has invested in Actylis.
-
Who are Actylis’s competitors?
WeylChem International, ABITEC, Celanese, Hallstar Innovations, and American Pacific are some of the 14 competitors of Actylis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process